OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,405 | -2.1% | 466 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,456 | +87.6% | 466 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $1,309 | -56.4% | 466 | -38.2% | 0.00% | -50.0% |
| Q3 2022 | $3,000 | -25.0% | 754 | -29.9% | 0.00% | -33.3% |
| Q2 2022 | $4,000 | -20.0% | 1,075 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | -44.4% | 1,075 | -14.5% | 0.00% | -40.0% |
| Q4 2021 | $9,000 | -30.8% | 1,257 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $13,000 | -27.8% | 1,257 | 0.0% | 0.01% | -27.3% |
| Q2 2021 | $18,000 | -43.8% | 1,257 | -36.4% | 0.01% | -47.6% |
| Q1 2021 | $32,000 | 0.0% | 1,976 | +26.6% | 0.02% | 0.0% |
| Q4 2020 | $32,000 | – | 1,561 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |